Tirzepatide 10 mg
This lot was tested by Janoshik. Purity was measured by RP-HPLC, 220 nm. The signed report is reproduced below; the figures on this page are transcribed from it.
- Batch number
- BK-TIRZ-10
- Compound
- Tirzepatide 10 mg
- Laboratory
- Janoshik
- Purity
- 99.81 % (RP-HPLC, 220 nm)
- Purity, RP-HPLC, 220 nm
- 99.81 %
- Laboratory
- Janoshik
What this certificate shows
Purity 99.81 %. Reversed-phase HPLC separates the contents of the vial by how they interact with the column, and a UV detector measures each peak. 99.81 % of the detected material in lot BK-TIRZ-10 is the target peptide, Tirzepatide 10 mg; the remaining 0.19 % is made up of closely related sequences and synthesis by-products. Purity describes what the peptide portion is, not how much powder is in the vial.
How each figure is measured, and the limits a lot must meet before release, are set out in our testing methods. For in-vitro laboratory research only.